fengabine has been researched along with clomipramine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ascalone, V; Cesana, B; Morselli, PL; Nielsen, NP; Priore, P; Zizolfi, S | 1 |
Garreau, M; Magni, G; Orofiamma, B; Palminteri, R | 1 |
Bartholini, G; Depoortere, H; Lloyd, KG; Sanger, D; Zivkovic, B | 1 |
2 trial(s) available for fengabine and clomipramine
Article | Year |
---|---|
Therapeutic effects of fengabine, a new GABAergic agent, in depressed outpatients: a double-blind study versus clomipramine.
Topics: Adult; Antidepressive Agents; Chlorophenols; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Psychiatric Status Rating Scales | 1990 |
Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics.
Topics: Adolescent; Adult; Amitriptyline; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Chlorophenols; Clinical Trials as Topic; Clomipramine; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Random Allocation | 1989 |
1 other study(ies) available for fengabine and clomipramine
Article | Year |
---|---|
Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
Topics: Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Bicuculline; Chlorophenols; Clomipramine; Depressive Disorder; Disease Models, Animal; gamma-Aminobutyric Acid; Imipramine; Male; Olfactory Bulb; Rats; Receptors, GABA-A; Seizures; Sleep | 1987 |